CSL's base fractionation facility in Broadmeadows, Australia has been recognised as the Overall Winner of the 2025 Facility of the Year Award (FOYA) by the International Society for Pharmaceutical ...
CSL Behring has announced a multi-year, $450 million two-site global capacity expansion - the latest in a series of recent production expansions to meet the growing need for its lifesaving and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback